Evaluation of the efficacy of NBUVB (narrow band UVB) phototherapy plus pioglitazone versus NBUVB phototherapy alone in the treatment of plaque type psoriasis
Phase 3
- Conditions
- Psoriasis.Plaque psoriasis
- Registration Number
- IRCT2016091918607N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
patients with plaque type psoriasis; indication of NBUVB phototherapy
Exclusion criteria: age under 18 years; treatment with phototherapy or systemic drugs of psoriasis during the last 3 months; pregnancy; lactation; congestive heart failure; renal diseases; liver diseases; pulmonary diseases
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PASI 75. Timepoint: Before treatment and 10 weeks after starting treatment. Method of measurement: Examination.
- Secondary Outcome Measures
Name Time Method Dermatology Life Quality Index (DLQI). Timepoint: Before treatment and 10 weeks after starting treatment. Method of measurement: Questionnaire.;Adverse effects. Timepoint: every month after starting treatment. Method of measurement: examination and asking from the patients.